© 2022 MJH Life Sciences™ and Ophthalmology Times. All rights reserved.
Latest Conference Articles
Your unrestricted view into eyecare conferences across the spectrum. Gain exclusive access to Ophthalmology Times® expert-led conference coverage from major meetings throughout the year featuring articles, videos, and insights shared by prominent experts of the ophthalmic community.
Study evaluates OC-01 (varenicline solution) as a treatment for symptoms and signs of dry eye
May 11th 2022
Takeaway: there doesn't seem to be a specific dry eye phenotype that does better or worse.
Cell therapy trial shows promising results for patients with advanced dry AMD
May 10th 2022
The OpRegen trial is a cell therapy trial, looking to explore potential safety and efficacy for patients with advanced dry age-related macular degeneration (AMD).
New PRO instrument helps measure patient experience with therapies such as anti-VEGF agents, lasers to treat their eye disease
May 9th 2022
Diana Do, MD, professor of ophthalmology at Stanford's Byers Eye Institute, presents research on a newly developed, novel patient-reported outcome instrument (PRO) for patients who have proliferative diabetic retinopathy and who are undergoing treatment with either intravitreal anti-VEGF therapy, or panretinal photocoagulation.
Dexamethasone plug opens opportunity for treatment that will bring patients relief, help alleviate and mitigate the signs and symptoms associated with conjunctivitis from allergies
May 6th 2022
A second FDA indication for the treatment of allergic conjunctivitis proves promising for patient relief.
New noninvasive technology shows positive safety and efficacy for the treatment of open angle glaucoma
May 5th 2022
Two year data shows a promising future for the OCD guided, noninvasive technology for glaucoma treatment.
Cataract classification method allows for higher success rates of cataract surgery
May 5th 2022
Alex Dastgheib, MD, ABO, discusses the findings of the paper, "325 Cases of Phacoemulsification in Blind Cataracts," presented at the 2022 ASCRS conference in Washington, DC. The paper won the Challenging Cases session during the meeting.
YOSEMITE and RHINE: 2-year results of faricimab in diabetic macular edema indicate reduced treatment burden
May 4th 2022
Jennifer I. Lim, MD, FARVO, FASRS, reviews the 2-year results of the YOSEMITE and RHINE trials, outlining the efficacy, durability, and safety of faricimab in diabetic macular edema.
Beyeonics One exoscope offers an immersive experience that allows for better patient and surgeon outcomes
May 4th 2022
Jonathan Solomon, MD, shares his personal experience using the Beyeonics One exoscope, highlighting what makes this tool stand out.
Retrospective study shows toric IOL rotation rate to be low at 2.1%
May 4th 2022
Edward Hu, MD, PhD, looked at 812 toric IOLs utilized of various platforms, concluding a low total toric rotation rate at 2.1%.
Pilot study examines spectacle lenses to control myopia
May 3rd 2022
In a poster presented at the Association for Research in Vision and Ophthalmology’s 2022 annual meeting in Denver, Eva Chamorro, PhD, MSc, points out that myopia control spectacle lenses affect the diurnal rhythms in the AL in young adult human and produced a small short-term increase in the AL that varies in intensity and time interval for each of the 3 studied lenses.